A Phase I Open-Label Dose-Escalation Study of Intravenous...

Clinical Lung Cancer 2013 Vol. 14; Iss. 1

A Phase I Open-Label Dose-Escalation Study of Intravenous BI 2536 Together With Pemetrexed in Previously Treated Patients With Non–Small-Cell Lung Cancer

Peter M. Ellis, Quincy S. Chu, Natasha Leighl, Scott A. Laurie, Holger Fritsch, Birgit Gaschler-Markefski, Steve Gyorffy, Gerd Munzert
How much do you like this book?
What’s the quality of the file?
Download the book for quality assessment
What’s the quality of the downloaded files?
Volume:
14
Year:
2013
Language:
english
DOI:
10.1016/j.cllc.2012.04.003
File:
PDF, 389 KB
english, 2013
Conversion to is in progress
Conversion to is failed